Supreme Court Declines ‘Skinny Label’ Case, But Teva To Continue Fight In District Court

 
• By Brenda Sandburg
  
Supreme Court building
Supreme Court declines to take up three pharma-related cases • Source: Shutterstock

More from Generics

More from Biosimilars & Generics